Cargando…
Drugs for life : how pharmaceutical companies define our health /
Joseph Dumit argues that underlying Americans' burgeoning consumption of prescription drugs and the skyrocketing cost of healthcare is a relatively new perception of ourselves as inherently ill and in need of chronic treatment.
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Durham, N.C. :
Duke University Press,
2012.
|
| Colección: | Experimental futures.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | JSTOR_ocn809653753 | ||
| 003 | OCoLC | ||
| 005 | 20231005004200.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 120911s2012 ncua ob 001 0 eng d | ||
| 010 | |z 2012011596 | ||
| 040 | |a CUS |b eng |e pn |c CUS |d YDXCP |d NDD |d GPM |d LRU |d E7B |d ZMC |d OCLCQ |d N$T |d CDX |d OCLCO |d MHW |d MEAUC |d OCLCF |d DEBSZ |d NAM |d NHM |d OCLCO |d AU@ |d OCLCQ |d Z5A |d OCLCO |d OCLCA |d MERUC |d OCLCO |d IOG |d GILDS |d OCLCA |d OTZ |d COCUF |d OCLCQ |d TKN |d CANPU |d OCLCO |d OCLCA |d BRX |d VDB |d OCLCO |d OCLCQ |d BWN |d SFB |d OCLCA |d OCLCE |d OCLCA |d VT2 |d OCLCQ |d U9X |d JSTOR |d LUN |d DEGRU |d LVT |d OCLCQ |d OCLCO |d AUD |d QGK |d UKAHL |d DGITA |d OCLCO |d KSU |d OCL |d OCLCQ |d INARC |d OCLCO | ||
| 015 | |a GBB272470 |2 bnb | ||
| 019 | |a 812251442 |a 880909112 |a 1055240250 |a 1078866762 |a 1086444092 |a 1125495765 |a 1136428743 |a 1141677143 |a 1142793009 |a 1153026816 |a 1154259871 |a 1167395177 |a 1170308114 |a 1170527243 |a 1229663719 |a 1236196440 |a 1245476656 |a 1266909696 |a 1303511290 |a 1391411221 |a 1391814344 | ||
| 020 | |a 9780822393481 |q (electronic bk.) | ||
| 020 | |a 0822393484 |q (electronic bk.) | ||
| 020 | |a 9786613904102 | ||
| 020 | |a 6613904104 | ||
| 020 | |a 1283591650 | ||
| 020 | |a 9781283591652 | ||
| 020 | |z 9780822348603 |q (cloth ; |q alk. paper) | ||
| 020 | |z 0822348608 |q (cloth ; |q alk. paper) | ||
| 020 | |z 9780822348719 |q (pbk. ; |q alk. paper) | ||
| 020 | |z 0822348713 |q (pbk. ; |q alk. paper) | ||
| 024 | 7 | |a 10.1515/9780822393481 |2 doi | |
| 024 | 8 | |a 9786613904102 | |
| 029 | 1 | |a AU@ |b 000052916883 | |
| 029 | 1 | |a AU@ |b 000055826664 | |
| 029 | 1 | |a CHNEW |b 000609903 | |
| 029 | 1 | |a DEBBG |b BV040869632 | |
| 029 | 1 | |a DEBBG |b BV042795422 | |
| 029 | 1 | |a DEBSZ |b 397528752 | |
| 029 | 1 | |a NZ1 |b 14927521 | |
| 035 | |a (OCoLC)809653753 |z (OCoLC)812251442 |z (OCoLC)880909112 |z (OCoLC)1055240250 |z (OCoLC)1078866762 |z (OCoLC)1086444092 |z (OCoLC)1125495765 |z (OCoLC)1136428743 |z (OCoLC)1141677143 |z (OCoLC)1142793009 |z (OCoLC)1153026816 |z (OCoLC)1154259871 |z (OCoLC)1167395177 |z (OCoLC)1170308114 |z (OCoLC)1170527243 |z (OCoLC)1229663719 |z (OCoLC)1236196440 |z (OCoLC)1245476656 |z (OCoLC)1266909696 |z (OCoLC)1303511290 |z (OCoLC)1391411221 |z (OCoLC)1391814344 | ||
| 037 | |a 390410 |b MIL | ||
| 037 | |a 22573/ctv123zfvb |b JSTOR | ||
| 042 | |a dlr | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a HD9666.5 |b .D86 2012eb | |
| 060 | 4 | |a 2012 H-499 | |
| 060 | 4 | |a QV 736 AA1 | |
| 072 | 7 | |a BUS |x 070130 |2 bisacsh | |
| 072 | 7 | |a SOC |x 002010 |2 bisacsh | |
| 072 | 7 | |a MED |x 037000 |2 bisacsh | |
| 082 | 0 | 4 | |a 338.4/761510973 |2 23 |
| 084 | |a 58.28 |2 bcl | ||
| 084 | |a LC 56000 |2 rvk |0 (DE-625)rvk/90662:772 | ||
| 049 | |a UAMI | ||
| 100 | 1 | |a Dumit, Joseph. | |
| 245 | 1 | 0 | |a Drugs for life : |b how pharmaceutical companies define our health / |c Joseph Dumit. |
| 246 | 3 | 0 | |a How pharmaceutical companies define our health |
| 260 | |a Durham, N.C. : |b Duke University Press, |c 2012. | ||
| 300 | |a 1 online resource (xii, 262 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file | ||
| 347 | |b PDF | ||
| 490 | 1 | |a Experimental futures | |
| 504 | |a Includes bibliographical references (pages 239-256) and index. | ||
| 588 | 0 | |a Online resource; title from digital title page (ebrary platform, viewed June 4, 2014). | |
| 505 | 0 | 0 | |t Responding to facts -- |t Pharmaceutical witnessing and direct-to-consumer advertising -- |t Having to grow medicine -- |t Mass health: illness is a line you cross -- |t Moving the lines: deciding on thresholds -- |t Knowing your numbers: pharmaceutical lifestyles -- |t Living in a world of surplus health: frequently asked questions. |
| 520 | |a Joseph Dumit argues that underlying Americans' burgeoning consumption of prescription drugs and the skyrocketing cost of healthcare is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. | ||
| 520 | |a "Every year the average number of prescriptions purchased by Americans increases, as do healthcare expenditures, which are projected to reach one fifth of the U.S. gross domestic product by 2020. In Drugs for Life, Joseph Dumit considers how our burgeoning consumption of medicine and cost of healthcare not only came to be, but came to be taken for granted. For several years, Dumit attended pharmaceutical industry conferences; spoke with marketers, researchers, doctors, and patients; and surveyed the industry's literature regarding strategies to expand markets for prescription drugs. He concluded that underlying the continual growth in medications, disease categories, costs, and insecurity is a relatively new perception of ourselves as inherently ill and in need of chronic treatment. This perception is based on clinical trials that we have largely outsourced to pharmaceutical companies. Those companies in turn see clinical trials as investments and measure the value of those investments by the size of the market they will create. They only ask questions for which the answer is more medicine. Drugs for Life challenges our understanding of health, risks, facts, and clinical trials, the very concepts used by pharmaceutical companies to grow markets to the point where almost no one can imagine a life without prescription drugs."--Provided by publisher | ||
| 546 | |a English. | ||
| 506 | |3 Use copy |f Restrictions unspecified |2 star |5 MiAaHDL | ||
| 533 | |a Electronic reproduction. |b [Place of publication not identified]: |c HathiTrust Digital Library. |d 2020. |5 MiAaHDL | ||
| 538 | |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002. |u http://purl.oclc.org/DLF/benchrepro0212 |5 MiAaHDL | ||
| 583 | 1 | |a digitized |c 2020. |h HathiTrust Digital Library |l committed to preserve |2 pda |5 MiAaHDL | |
| 590 | |a JSTOR |b Books at JSTOR All Purchased | ||
| 590 | |a JSTOR |b Books at JSTOR Demand Driven Acquisitions (DDA) | ||
| 610 | 2 | 7 | |a Umschulungswerkstätten für Siedler und Auswanderer |g Bitterfeld |2 gnd |
| 650 | 0 | |a Pharmaceutical industry |x Social aspects |z United States. | |
| 650 | 0 | |a Drugs |x Social aspects |z United States. | |
| 650 | 0 | |a Drug utilization |z United States. | |
| 650 | 0 | |a Social ecology. | |
| 650 | 2 | |a Community Participation | |
| 650 | 2 | |a Social Environment | |
| 650 | 6 | |a Industrie pharmaceutique |x Aspect social |z États-Unis. | |
| 650 | 6 | |a Médicaments |x Aspect social |z États-Unis. | |
| 650 | 6 | |a Médicaments |x Usage |z États-Unis. | |
| 650 | 6 | |a Écologie sociale. | |
| 650 | 7 | |a human ecology. |2 aat | |
| 650 | 7 | |a BUSINESS & ECONOMICS |x Industries |x Pharmaceutical & Biotechnology. |2 bisacsh | |
| 650 | 7 | |a SOCIAL SCIENCE |x Anthropology |x Cultural. |2 bisacsh | |
| 650 | 7 | |a Industry. |2 eflch | |
| 650 | 7 | |a Social ecology |2 fast | |
| 650 | 7 | |a Drug utilization |2 fast | |
| 650 | 7 | |a Drugs |x Social aspects |2 fast | |
| 650 | 7 | |a Pharmaceutical industry |x Social aspects |2 fast | |
| 651 | 7 | |a United States |2 fast | |
| 650 | 7 | |a Pharmazeutische Industrie |2 gnd | |
| 650 | 7 | |a Arzneimittelmarkt |2 gnd | |
| 650 | 7 | |a Medizinische Ethik |2 gnd | |
| 650 | 7 | |a Arzneimittelkonsum |2 gnd | |
| 650 | 1 | 7 | |a Drugs. |2 gtt |
| 650 | 1 | 7 | |a Sociale aspecten. |2 gtt |
| 651 | 7 | |a Verenigde Staten. |2 gtt | |
| 651 | 7 | |a Etats-Unis. |2 rero | |
| 776 | 0 | 8 | |i Print version: |a Dumit, Joseph. |t Drugs for life. |d Durham, NC : Duke University Press, 2012 |z 9780822348603 |z 0822348608 |w (DLC) 2012011596 |w (OCoLC)782252371 |
| 830 | 0 | |a Experimental futures. | |
| 856 | 4 | 0 | |u https://jstor.uam.elogim.com/stable/10.2307/j.ctv125jgdj |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH28320226 | ||
| 938 | |a Coutts Information Services |b COUT |n 23408934 | ||
| 938 | |a De Gruyter |b DEGR |n 9780822393481 | ||
| 938 | |a Digitalia Publishing |b DGIT |n DIGDUKEUP0156 | ||
| 938 | |a ebrary |b EBRY |n ebr10598775 | ||
| 938 | |a EBSCOhost |b EBSC |n 599867 | ||
| 938 | |a Project MUSE |b MUSE |n muse79914 | ||
| 938 | |a YBP Library Services |b YANK |n 7641616 | ||
| 938 | |a Internet Archive |b INAR |n drugsforlifehowp0000dumi | ||
| 994 | |a 92 |b IZTAP | ||